EP0426830A1 - Method of enhancing growth of anchorage dependent cells - Google Patents

Method of enhancing growth of anchorage dependent cells

Info

Publication number
EP0426830A1
EP0426830A1 EP90908822A EP90908822A EP0426830A1 EP 0426830 A1 EP0426830 A1 EP 0426830A1 EP 90908822 A EP90908822 A EP 90908822A EP 90908822 A EP90908822 A EP 90908822A EP 0426830 A1 EP0426830 A1 EP 0426830A1
Authority
EP
European Patent Office
Prior art keywords
groups
hollow fiber
cells
anchorage
pendent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP90908822A
Other languages
German (de)
French (fr)
Other versions
EP0426830A4 (en
Inventor
Timothy Conrad Gebhard
Uday Kumar Veeramallu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UniSyn Technologies Inc
Original Assignee
Synbiotics LLC
UniSyn Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synbiotics LLC, UniSyn Technologies Inc filed Critical Synbiotics LLC
Publication of EP0426830A1 publication Critical patent/EP0426830A1/en
Publication of EP0426830A4 publication Critical patent/EP0426830A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068General culture methods using substrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/30Synthetic polymers

Definitions

  • the invention generally relates to a method of enhancing growth of anchorage-dependent cells in hollow fiber membrane cell culture bioreactors, and in particular, to obtaining such enhanced growth through the use of certain polymeric hollow fiber membranes.
  • Cell culture devices for culturing cells in vitro having a shell with a plurality of hollow fiber membranes have been known for quite some time.
  • Medium containing oxygen, nutrients and other chemical stimuli is transported through the lumen of the hollow fiber membranes.
  • Nutrients and gases are carried across the hollow fiber membranes by diffusion and outward convective flow.
  • Cells are grown in the fluid space between the fibers and the shell wall.
  • Hollow fiber culture devices have been proven to be ideal for the maintenance of many types of cells at high densities in vitro.
  • the mass transfer characteristics of hollow fiber culture devices provide an efficient means of delivering nutrients and gases and removing waste products from a culture.
  • the semi-porous hollow fiber membranes can be selected with various pore sizes. With proper pore size selection, the cellular product can be maintained on the outside of the fibers, while waste products and contaminating proteins will pass through the membrane pores into the lumen of the hollow fibers where they can be subsequently removed from the culture.
  • Examples of prior art cell culturing devices include U.S. Patent No. 4,804,628 and patents cited therein.
  • Examples of materials used in prior art hollow fiber membranes include cellulose acetate, silicone carbonate and capillaries coated with collagen (U.S. Patent No. 3,821,087) and a great variety of natural and synthetic polymeric materials including polyacrylics such as polymethylmethacrylate (U.S. Patent No. 4,546,083).
  • U.S. Patent No. 4,439,322 describes ionic crosslinked polymethylmethacrylate copolymers containing pendent sulfonate and quaternary nitrogen groups in the form of hollow fibers useful in blood purification, i.e., dialysis.
  • Ramsay, et.al. "Surface Treatments and Cell Attachment," In Vitro, Vol. 20, No. 10 (1984) discloses that untreated polymethylmethacrylate sheets have relatively poor adhesiveness to anchorage-dependent cells.
  • FIGS. 1 and 2 are photomicrographs of cellulose membranes taken at 2OX and 33X magnification, respectively.
  • Figures 3 and 4 are photomiocrographs of ionic crosslinked PMMA membranes made according to the invention at 2OX and SOX magnification, respectively.
  • a problem with anchorage-dependent cell production in hollow fiber bioreactors is identifying suitable materials from which to manufacture hollow fiber membranes which allow optimum cell growth and product production.
  • the invention therefore relates to a method of enhancing growth of anchorage-dependent cells on hollow fiber membranes comprising employing hollow fiber membranes comprising an ionic crosslinked polymer containing from about 0.5 to about 20 mol% of pendent groups selected from the group consisting of anionic and cationic substituents and salts thereof which are ionizable at physiological pH.
  • the invention also relates to a method of enhancing growth of anchorage-dependent cells on hollow fiber membranes, wherein the membranes comprise a mixture of methylmethacrylate copolymer containing about 0.5 to 10 mol% of a monomer having pendent sulfonate groups, and a methylmethacrylate copolymer containing about 0.5 to 10 mol% of a monomer having pendent quaternary nitrogen-containing groups.
  • the polymers which may be used in this invention in the form of hollow fibers are polymers, preferably ionic, crosslinked polymers, having from about 0.5 to about 20 mol% and preferably from about 1 to about 5 mol% and especially from..about 2 to about 4 mol% of pendant groups that are ionizable at physiological pH.
  • the ionizable groups may be either anionic or cationic and include the substituents and salts thereof listed below.
  • copolymers containing anionic groups can be combined with copolymers containing cationic groups to yield ionic crosslinked polymers.
  • Preferred blends of the foregoing copolymers include those blends resulting in a ratio between about 5:1 and 1:5 and preferably a slight excess of ionic groups of either type, e.g. , about 1.1:1.
  • Preferred polymers are copolymers of polymethylmethacrylate (PMMA) .
  • PMMA polymethylmethacrylate
  • other conventional polymers may be added for modification of physical properties even though they may not have pendent ionizable groups.
  • Cationic groups include conventional quaternary nitrogen-containing groups and their salts.
  • Preferred salts include halide and sulfate salts and especially chloride salts.
  • Anionic groups include sulfonate groups, such as, for example, sulfonic acid; and carboxylic acid groups and their salts.
  • Typical salts are metal cations, e.g., mono-, di- or tri- valent cations, i.e., sodium, potassium, calcium, aluminum, etc., and especially sodium salts.
  • PMMA membranes which may be used in this invention and their method of manufacture are described in detail in U.S. Patent No. 4,439,322, which patent is incorporated by this reference.
  • a preferred PMMA membrane consists of two kinds of polymers: a) a methylmethacrylate copolymer containing about 0.5 to 10 mol% of a monomer having pendent sulfonate groups, and b) a methylmethacrylate copolymer containing about 0.5 to 10 mol% of a monomer having pendent quaternary nitrogen-containing groups.
  • the membrane which is manufactured therefrom is an ionically crosslinked polyion complex membrane.
  • the two copolymers may be mixed in a weight ratio of about 1:9 to 9:1.
  • This mix ratio is preferably selected to ensure that the numbers of the sulfonate and quaternary nitrogen-containing groups in the copolymers have a ratio of about 5:1 to 1:5, preferably about 2:1 to 1:2.
  • an ion complex should be formed of substantially equal numbers of sulfonate and quaternary nitrogren-containing groups.
  • the hollow fiber membrane which may be used in the invention has a substantially circular hollow cross section, a uniform wall thickness in the range of about 5 to 500 microns, and an inside diameter of about 70 to 1,000 microns. Porosity of the membrane is engineered to provide a molecular weight exclusion range of 6 Kd to about 3000 Kd.
  • anchorage-dependent cell lines include normal diploid cell strains, such as human embryonic lung, human foreskin, human embryonic kidney, chicken, rabbit, mouse and rat embryo fibroblasts, chimpanzee liver fibroblasts, rat glial cells, feline lung fibroblasts and secondary monkey kidney cells; primary cells, such as monkey, dog and rabbit kidney cells, mouse macrophages, rat pancreas cells, rat hepatocytes, chicken embryo fibroblasts, rat pituitary cells and amniotic fluid cells; established and transformed cell lines, such as mouse fibroblasts, normal rat kidney, Chinese hamster ovary and lung, baby hamster kidney, chimpanzee embryo lung, African green monkey kidney, mouse L cells, HeLa, mouse macrophage cell line, transformed dog kidney, sarcoma virus transformed rat kidney and mouse fibroblasts, human glioma, human osteosarcoma, Madin-Darby canine kidney, KB cells, rhesus monkey
  • System Configuration - Hollow fiber bioreactors are well suited to the culture of a human glioma cell line.
  • the ionic crosslinked polymethylmethacrylate (PMMA) hollow fibers allow excellent attachment of cells in the extra capillary space (ECS) of the bioreactor.
  • ECS extra capillary space
  • a cell-free stream flows through the lumen of the fibers and undergoes diffusive exchange of nutrients and metabolic wastes with the cell mass.
  • the large surface area (2.0 m 2 ) in the bioreactor provides efficient mass transfer, and tissue like cell densities are achieved.
  • Glioma-mesenchymal extra cellular matrix protein GMEM
  • MWCO molecular weight cut off
  • a conventional bioreactor was configured in a recirculation flow loop that starts and ends in an integrating reservoir.
  • An oscillating pump drives the loop at 400 ml/min.
  • An oxygenator was located upstream of the bioreactor for oxygen replenishment.
  • An air pump provides a controlled air flow rate to the oxygenator.
  • a peristaltic infusion pump feeds fresh medium into the reservoir.
  • a separate peristaltic pump was used to deliver serum to the bioreactor ECS, as well as harvest GMEM.
  • the temperature and pH of the culture medium were monitored in the reservoir. Temperature was maintained constant at 37 ⁇ C and the pH was maintained at 7.25 using a carbon dioxide/bicarbonate buffering system.
  • System Assembly and Sterilization The auto- clavable portion of the hollow fiber system is pre-assembled and sterilized. The sterile-packed hollow fiber bioreactor and oxygenator are incorporated sterilely into the system. The completed assembly is transferred into a benchtop system chamber. All accessories, e.g., carboys, bottles, gas lines and instrumentation are connected to the assembly.
  • Inoculum Generation A single vial of glioma cells (about 2.5xl0 6 ) is reconstituted and expanded in complete medium using T-flasks.
  • the complete medium consists of Dulbecco's Modified Eagle's Medium (DMEM) with 10% Fetal Bovine Serum (FBS) , 2% L-glutamine.
  • DMEM Dulbecco's Modified Eagle's Medium
  • FBS Fetal Bovine Serum
  • Viable cells are counted on a hemocytometer using the trypan blue exclusion method.
  • a suitable inoculum was obtained from T-175 flasks. The culture was centrifuged, resuspended in the medium, and transferred into an inoculation bottle. Generation of inoculum takes about 10 days.
  • the ECS feed line is flushed of residual inoculum with an appropriate volume of DMEM containing FBS.
  • the "growth phase” dedicated to rapid generation of cell mass, was initiated by conditions optimal for cell growth.
  • the infusion rate is stepped up to keep up with the proliferating cell mass.
  • the cells then shift from a proliferative to a maintenance state (third week) .
  • the growth of cells is then halted, but their viability and activity is preserved.
  • the remainder of the run is the "production phase”, dedicated to the production of GMEM which is maintained at 2 mg/ml for the next 4 weeks, and harvested at a rate of 70 mg/day.
  • CRFK Crandell Feline Kidney Cells
  • Described below is a method for culturing cells with hollow fiber materials in vitro to determine 1) the cell's substrate preference and 2) the potential application of the substrate material in hollow fiber cell culture. This procedure was used to again demonstrate the advantage of ionic crosslinked PMMA as a substrate for the effective culturing of anchorage-dependent cells.
  • Cellulose "C-Dak” dialyzer series, CD. Medical. 2. The fibers were placed into a beaker of distilled water and subsequently rinsed several times with large amounts of distilled water.
  • PMMA (50X) In Fig. 4, a close up of the PMMA fiber, cells are shown adhering to the entire outer surface of the hollow fiber. This was common on all PMMA fibers in the culture.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne un procédé améliorant la croissance de lignées cellulaires dépendant de la fixation dans des bioréacteurs de culture de cellules de membranes à fibres creuses en utilisant des membranes à fibres creuses constituées d'un polymère ionique réticulé, de préférence du polyméthylméthacrylate, contenant des substituants cationiques et/ou anioniques qui sont ionisables à un pH physiologique.The invention relates to a method for improving the growth of attachment-dependent cell lines in hollow fiber membrane cell culture bioreactors using hollow fiber membranes made of a cross-linked ionic polymer, preferably polymethylmethacrylate, containing cationic and/or anionic substituents which are ionizable at physiological pH.

Description

METHOD OF ENHANCING GROWTH OF ANCHORAGE DEPENDENT CELLS
This application is a continuation of United States application Serial No. 07/355,590 filed 23 May 1989, which is still pending.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention generally relates to a method of enhancing growth of anchorage-dependent cells in hollow fiber membrane cell culture bioreactors, and in particular, to obtaining such enhanced growth through the use of certain polymeric hollow fiber membranes.
2. Description of the Prior Art
a. Cell Culture Devices
Cell culture devices for culturing cells .in vitro having a shell with a plurality of hollow fiber membranes have been known for quite some time. Medium containing oxygen, nutrients and other chemical stimuli is transported through the lumen of the hollow fiber membranes. Nutrients and gases are carried across the hollow fiber membranes by diffusion and outward convective flow. Cells are grown in the fluid space between the fibers and the shell wall.
Hollow fiber culture devices have been proven to be ideal for the maintenance of many types of cells at high densities in vitro. The mass transfer characteristics of hollow fiber culture devices provide an efficient means of delivering nutrients and gases and removing waste products from a culture. The semi-porous hollow fiber membranes can be selected with various pore sizes. With proper pore size selection, the cellular product can be maintained on the outside of the fibers, while waste products and contaminating proteins will pass through the membrane pores into the lumen of the hollow fibers where they can be subsequently removed from the culture.
Examples of prior art cell culturing devices include U.S. Patent No. 4,804,628 and patents cited therein. Examples of materials used in prior art hollow fiber membranes include cellulose acetate, silicone carbonate and capillaries coated with collagen (U.S. Patent No. 3,821,087) and a great variety of natural and synthetic polymeric materials including polyacrylics such as polymethylmethacrylate (U.S. Patent No. 4,546,083). U.S. Patent No. 4,439,322 describes ionic crosslinked polymethylmethacrylate copolymers containing pendent sulfonate and quaternary nitrogen groups in the form of hollow fibers useful in blood purification, i.e., dialysis. Ramsay, et.al. , "Surface Treatments and Cell Attachment," In Vitro, Vol. 20, No. 10 (1984) discloses that untreated polymethylmethacrylate sheets have relatively poor adhesiveness to anchorage-dependent cells.
b. Anchorage-Dependent Cells
Most mammalian cells are cultured as attached to a substrate for which they exhibit a physical or chemical affinity. Exceptions to this mode are notable and usually belong to hemapoietic cell groups or malignantly transformed cell lines. Freedom from attachment greatly facilitates the culture of such cells in suspension. However, a large group of cell lines with potential or established industrial value fall into the category of dedicated anchorage-dependence. The bulk of high market value proteins fall into this group as a result of recombinant-transfected cells and malignantly transformed cell lines. Cell attachment and spreading offer functional advantages fundamental for growth and differentiation. Attached and spread cells have a significantly higher surface area to volume ratio than do spherical cells. This increase in surface area results in more receptor sites for mitotic stimulators/regulators required by anchorage-dependent cells.
BRIEF DESCRIPTION OF THE DRAWINGS
The drawings are photomicrographs of hollow fiber membranes. Figures 1 and 2 are photomicrographs of cellulose membranes taken at 2OX and 33X magnification, respectively. Figures 3 and 4 are photomiocrographs of ionic crosslinked PMMA membranes made according to the invention at 2OX and SOX magnification, respectively.
SUMMARY OF THE INVENTION
A problem with anchorage-dependent cell production in hollow fiber bioreactors is identifying suitable materials from which to manufacture hollow fiber membranes which allow optimum cell growth and product production.
We have now discovered that certain ionic, crosslinked polymers unexpectedly provide an excellent material for optimum growth of anchorage-dependent cells in hollow fiber bioreactors.
The invention therefore relates to a method of enhancing growth of anchorage-dependent cells on hollow fiber membranes comprising employing hollow fiber membranes comprising an ionic crosslinked polymer containing from about 0.5 to about 20 mol% of pendent groups selected from the group consisting of anionic and cationic substituents and salts thereof which are ionizable at physiological pH.
The invention also relates to a method of enhancing growth of anchorage-dependent cells on hollow fiber membranes, wherein the membranes comprise a mixture of methylmethacrylate copolymer containing about 0.5 to 10 mol% of a monomer having pendent sulfonate groups, and a methylmethacrylate copolymer containing about 0.5 to 10 mol% of a monomer having pendent quaternary nitrogen-containing groups.
DESCRIPTION OF THE INVENTION
The polymers which may be used in this invention in the form of hollow fibers are polymers, preferably ionic, crosslinked polymers, having from about 0.5 to about 20 mol% and preferably from about 1 to about 5 mol% and especially from..about 2 to about 4 mol% of pendant groups that are ionizable at physiological pH. The ionizable groups may be either anionic or cationic and include the substituents and salts thereof listed below. Further, copolymers containing anionic groups can be combined with copolymers containing cationic groups to yield ionic crosslinked polymers. Preferred blends of the foregoing copolymers include those blends resulting in a ratio between about 5:1 and 1:5 and preferably a slight excess of ionic groups of either type, e.g. , about 1.1:1.
Preferred polymers are copolymers of polymethylmethacrylate (PMMA) . In addition, other conventional polymers may be added for modification of physical properties even though they may not have pendent ionizable groups.
Cationic groups include conventional quaternary nitrogen-containing groups and their salts. Preferred salts include halide and sulfate salts and especially chloride salts. Anionic groups include sulfonate groups, such as, for example, sulfonic acid; and carboxylic acid groups and their salts. Typical salts are metal cations, e.g., mono-, di- or tri- valent cations, i.e., sodium, potassium, calcium, aluminum, etc., and especially sodium salts.
Preferred polymethylmethacrylate (PMMA) membranes which may be used in this invention and their method of manufacture are described in detail in U.S. Patent No. 4,439,322, which patent is incorporated by this reference.
A preferred PMMA membrane consists of two kinds of polymers: a) a methylmethacrylate copolymer containing about 0.5 to 10 mol% of a monomer having pendent sulfonate groups, and b) a methylmethacrylate copolymer containing about 0.5 to 10 mol% of a monomer having pendent quaternary nitrogen-containing groups.
As one of the copolymers is of the polyanionic type having sulfonate groups, and the other of the polycationic type having quaternary nitrogen- containing groups, the membrane which is manufactured therefrom is an ionically crosslinked polyion complex membrane.
The two copolymers may be mixed in a weight ratio of about 1:9 to 9:1. This mix ratio is preferably selected to ensure that the numbers of the sulfonate and quaternary nitrogen-containing groups in the copolymers have a ratio of about 5:1 to 1:5, preferably about 2:1 to 1:2. From the standpoint of membrane strength, an ion complex should be formed of substantially equal numbers of sulfonate and quaternary nitrogren-containing groups. However, it is preferable to employ a mix ratio which ensures that the numbers of the sulfonate and quaternary nitrogen-containing groups in the copolymers have a ratio so that the membrane is either anionic or cationic.
The hollow fiber membrane which may be used in the invention has a substantially circular hollow cross section, a uniform wall thickness in the range of about 5 to 500 microns, and an inside diameter of about 70 to 1,000 microns. Porosity of the membrane is engineered to provide a molecular weight exclusion range of 6 Kd to about 3000 Kd.
Typical examples of anchorage-dependent cell lines include normal diploid cell strains, such as human embryonic lung, human foreskin, human embryonic kidney, chicken, rabbit, mouse and rat embryo fibroblasts, chimpanzee liver fibroblasts, rat glial cells, feline lung fibroblasts and secondary monkey kidney cells; primary cells, such as monkey, dog and rabbit kidney cells, mouse macrophages, rat pancreas cells, rat hepatocytes, chicken embryo fibroblasts, rat pituitary cells and amniotic fluid cells; established and transformed cell lines, such as mouse fibroblasts, normal rat kidney, Chinese hamster ovary and lung, baby hamster kidney, chimpanzee embryo lung, African green monkey kidney, mouse L cells, HeLa, mouse macrophage cell line, transformed dog kidney, sarcoma virus transformed rat kidney and mouse fibroblasts, human glioma, human osteosarcoma, Madin-Darby canine kidney, KB cells, rhesus monkey kidney, McCoy cells, human thyroid carcinoma, human rhabdomyosarcoma, rat muscle derived fibroblasts and rabbit cornea cells.
The invention will now be described more specifically with reference to the following Examples, which are intended to be illustrative, but not to define or to limit the scope of the invention, which is defined in the appended claims. EXAMPLE I Culture of an Anchorage-Dependent Human Glioma Cell Line in a Hollow Fiber Bioreactor System
System Configuration - Hollow fiber bioreactors are well suited to the culture of a human glioma cell line. The ionic crosslinked polymethylmethacrylate (PMMA) hollow fibers (Toray "Filtryzer" dialyzer series) allow excellent attachment of cells in the extra capillary space (ECS) of the bioreactor. A cell-free stream flows through the lumen of the fibers and undergoes diffusive exchange of nutrients and metabolic wastes with the cell mass. The large surface area (2.0 m2) in the bioreactor provides efficient mass transfer, and tissue like cell densities are achieved. Glioma-mesenchymal extra cellular matrix protein (GMEM) , a 1000 Kd glycoprotein, is secreted by the cells in the ECS and recovered in situ by virtue of the 10 Kd molecular weight cut off (MWCO) of the hollow fiber membranes.
A conventional bioreactor was configured in a recirculation flow loop that starts and ends in an integrating reservoir. An oscillating pump drives the loop at 400 ml/min. An oxygenator was located upstream of the bioreactor for oxygen replenishment. An air pump provides a controlled air flow rate to the oxygenator. A peristaltic infusion pump feeds fresh medium into the reservoir. A separate peristaltic pump was used to deliver serum to the bioreactor ECS, as well as harvest GMEM.
The temperature and pH of the culture medium were monitored in the reservoir. Temperature was maintained constant at 37βC and the pH was maintained at 7.25 using a carbon dioxide/bicarbonate buffering system. System Assembly and Sterilization - The auto- clavable portion of the hollow fiber system is pre-assembled and sterilized. The sterile-packed hollow fiber bioreactor and oxygenator are incorporated sterilely into the system. The completed assembly is transferred into a benchtop system chamber. All accessories, e.g., carboys, bottles, gas lines and instrumentation are connected to the assembly.
Inoculum Generation - A single vial of glioma cells (about 2.5xl06) is reconstituted and expanded in complete medium using T-flasks. The complete medium consists of Dulbecco's Modified Eagle's Medium (DMEM) with 10% Fetal Bovine Serum (FBS) , 2% L-glutamine. During flash transfers, the cells are recovered by washing with buffered saline, trypsinization and resuspension in fresh medium. Viable cells are counted on a hemocytometer using the trypan blue exclusion method. A suitable inoculum was obtained from T-175 flasks. The culture was centrifuged, resuspended in the medium, and transferred into an inoculation bottle. Generation of inoculum takes about 10 days.
Inoculation - After the inoculum is loaded into the bioreactor ECS, the ECS feed line is flushed of residual inoculum with an appropriate volume of DMEM containing FBS.
Production - After inoculation, the "growth phase", dedicated to rapid generation of cell mass, was initiated by conditions optimal for cell growth. The infusion rate is stepped up to keep up with the proliferating cell mass. The cells then shift from a proliferative to a maintenance state (third week) . The growth of cells is then halted, but their viability and activity is preserved. The remainder of the run is the "production phase", dedicated to the production of GMEM which is maintained at 2 mg/ml for the next 4 weeks, and harvested at a rate of 70 mg/day.
EXAMPLE II Anchorage-Dependent Cell Growth with Ionic Crosslinked PMMA and Cellulose Hollow Fibers
To further illustrate that anchorage-dependent cell lines grow favorably on ionic crosslinked PMMA substrates, another such cell line was cultured in vitro with ionic crosslinked PMMA and with cellulose hollow fibers. Crandell Feline Kidney Cells (CRFK) are an anchorage-dependent cell line of an epithelial nature that were used for this purpose. Described below is a method for culturing cells with hollow fiber materials in vitro to determine 1) the cell's substrate preference and 2) the potential application of the substrate material in hollow fiber cell culture. This procedure was used to again demonstrate the advantage of ionic crosslinked PMMA as a substrate for the effective culturing of anchorage-dependent cells.
Materials and Methods - Two different sources of hollow fiber materials were used; ionic crosslinked PMMA and Cellulose. The fibers were washed, autoclaved sterile, and placed into independent T-flasks seeded with equal cultures of CRFK cells. The cultures were allowed to grow undisturbed for a period of time. After that time period, observations and photomicrographs of the culture were taken.
1. Hollow fiber bioreactors, one containing the PMMA and another containing the Cellulose fibers, were opened and extracted of their fibers. Source of fibers:
PMMA: "Filtryzer" dialyzer series, Toray
Cellulose: "C-Dak" dialyzer series, CD. Medical. 2. The fibers were placed into a beaker of distilled water and subsequently rinsed several times with large amounts of distilled water.
3. A small number of fibers were needed for each culture; therefore, a bunch of fibers approximately 1-2 cm3 in volume were placed in a beaker of distilled water. The fibers to be used were autoclaved sterile in the beaker (thirty minutes, wet cycle) .
4. After sterilization, the fibers were placed into independent T175 tissue culture flasks.
5. Into both the PMMA and Cellulose fiber containing flasks, 50.0 mis of a CRFK culture at a cell concentration of 4.0xl05 cells/ml was added. The culture media- consisted of DME High Glucose (Irvine) supplemented with 10% fetal bovine serum (Hyclone) and 2% L-glutamine (Whittaker) .
6. Both flasks were placed into an incubator set at 37βC, under 7.5% C02.
7. Observations of the cultures and their growth progress were made under microscopic examination at various times after initiating the experiment. On day 4 of the experiment, photomicrographs were taken.
Observations - The cell grew well on both flasks' surface as would be expected; however, only the PMMA fibers displayed cell attachment and growth. No cell growth was observed on the Cellulose fibers. The difference between the two fibers' ability to promote growth of the CRFK cells is clear in the photomicrographs. Photomicrograph Legend:
1. Cellulose (20x) No cell growth is
2. Cellulose (33x) observed on the cellulose fibers (Figs. 1 and 2) . Note the presence of cells nearby the fibers, yet no interaction between the two is seen.
3. PMMA (20X) In Fig. 3, cells are observed growing all over the fiber surface and cell contrast can be seen easily on the edges.
4. PMMA (50X) In Fig. 4, a close up of the PMMA fiber, cells are shown adhering to the entire outer surface of the hollow fiber. This was common on all PMMA fibers in the culture.

Claims

WE CLAIM:
1. A method of enhancing growth of anchorage-dependent cells on hollow fiber membranes comprising employing hollow fiber membranes comprising an ionic crosslinked polymer containing from about 0.5 to about 20 ol percent of pendent groups selected from the group consisting of anionic and cationic substituents and salts thereof which are ionizable at physiological pH.
2. The method of Claim 1 wherein the cationic substituent is selected from the group consisting of quaternary nitrogen-containing groups and salts thereof.
3. The method of Claim 1 wherein the anionic substituent is selected from the group consisting of sulfonate groups, carboxylic acid groups and salts thereof.
4. The method of Claim 1 wherein the polymer comprises copolymers containing the anionic substituents blended with copolymers containing the cationic substituents.
5. A method of enhancing growth of anchorage- dependent cells on hollow fiber membranes, wherein the membranes comprise a mixture of a methylmethacrylate copolymer containing about 0.5 to 10 mol% of a monomer having pendent sulfonate groups, and a methylmethacrylate copolymer containing about 0.5 to 10 mol% of a monomer having pendent quaternary nitrogen-containing groups.
6. The method of Claim 5 wherein the sulfonate- containing groups and the quaternary nitrogen- containing groups in the copolymers are in a ratio between about 5:1 and 1:5.
7. The method of Claim 5 further including in the copolymer a vinyl monomer.
8. The method of Claim 1 wherein the anchorage- dependent cells are human glioma cells.
9. A method of Claim 5 wherein the anchorage- dependent cells are human glioma cells.
10. A method of enhancing growth of anchorage- dependent cells on hollow fiber membranes in cell culture bioreactors comprising employing hollow fiber membranes comprising a methylmethacrylate copolymer containing about 1 to about 5 mol percent of a monomer containing pendent sulfonate groups and about 1 to about 5 mol percent of a monomer containing pendent quaternary nitrogen-containing groups, the copolymer containing a slight excess of either of the pendent groups.
EP19900908822 1989-05-23 1990-05-23 Method of enhancing growth of anchorage dependent cells Withdrawn EP0426830A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35559089A 1989-05-23 1989-05-23
US355590 1989-05-23

Publications (2)

Publication Number Publication Date
EP0426830A1 true EP0426830A1 (en) 1991-05-15
EP0426830A4 EP0426830A4 (en) 1993-09-08

Family

ID=23398016

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19900908822 Withdrawn EP0426830A4 (en) 1989-05-23 1990-05-23 Method of enhancing growth of anchorage dependent cells

Country Status (3)

Country Link
EP (1) EP0426830A4 (en)
JP (1) JPH04501806A (en)
WO (1) WO1990014417A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0567886A3 (en) * 1992-04-21 1994-11-02 Kurashiki Boseki Kk Coating composition for culturing animal adhesive cells and method for culturing of the cells in serum-free condition.
BE1008955A3 (en) * 1994-11-14 1996-10-01 Univ Catholique Louvain Process for obtaining and products obtained biomaterials.
US5618718A (en) * 1994-12-30 1997-04-08 Universite Laval Production of a contractile smooth muscle

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883393A (en) * 1972-05-18 1975-05-13 Us Health Education & Welfare Cell culture on semi-permeable tubular membranes
US3910819A (en) * 1974-02-19 1975-10-07 California Inst Of Techn Treatment of surfaces to stimulate biological cell adhesion and growth
JPS5714640A (en) * 1980-07-02 1982-01-25 Toray Ind Inc Separating membrane of methyl methacrylate type
JPS5889179A (en) * 1981-11-24 1983-05-27 Japan Synthetic Rubber Co Ltd Cell culture bed

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9014417A1 *

Also Published As

Publication number Publication date
EP0426830A4 (en) 1993-09-08
WO1990014417A1 (en) 1990-11-29
JPH04501806A (en) 1992-04-02

Similar Documents

Publication Publication Date Title
US3997396A (en) Method for the in vitro propagation and maintenance of cells
US5622857A (en) High performance cell culture bioreactor and method
US4024020A (en) Method of cell culture on polyacrylonitrile surface
WO2008005520A2 (en) Temperature-responsive microcarrier
US20210062147A1 (en) Method of manufacturing or differentiating mammalian pluripotent stem cellsor progenitor cells using a hollow fiber bioreactor
CN109890959A (en) The serum free suspension liquid system of lentivirus production
EP0905231B1 (en) Method for increasing the stability and/or shelf-life of various substrates
Takazawa et al. High cell density perfusion culture of hybridoma cells recycling high molecular weight components
JPH08511173A (en) Culture medium additives for bioreactors
CN107236761B (en) Method for improving transient transfection and stable expression protein expression quantity of insect cells
EP0426830A1 (en) Method of enhancing growth of anchorage dependent cells
US20050196828A1 (en) Bioreactor with expandable surface area for culturing cells
Hirtenstein et al. Microcarrier-bound mammalian cells
JPH11243948A (en) Cell culture bed substrate for proliferation of animal cell and its preparation
JPH0156051B2 (en)
Strand et al. A modified matrix perfusion–microcarrier bead cell culture system. I. Adaptation of the matrix perfusion system for growth of human foreskin fibroblasts
Lazar et al. An immobilized hybridoma culture perfusion system for production of monoclonal antibodies
KR101639454B1 (en) Scalable process for culturing per.c6 cells and producing products therefrom
JP2010046053A (en) Sheet-shaped animal cell aggregation-cultured composition and method for making the same
Duvar et al. Scale up cultivation of primary human umbilical vein endothelial cells on microcarriers from spinner vessels to bioreactor fermentation
EP0216771A1 (en) Methods for culturing diploid cells on cellulose fibers
JPH10108673A (en) Culture of animal cell using hollow yarn type incubator
Hu Quantitative and mechanistic analysis of mammalian cell cultivation on microcarriers
Lazar Immobilization of animal cells in fixed bed bioreactors
RU2768962C1 (en) TCh (TESTIS CAPRA hircus), TRANSPLANTABLE MONOLAYER SUBLINE OF TESTICLE CELLS OF A MONTH-OLD GOATLING INTENDED FOR REPRODUCTION OF SMALLPOX VIRUSES, PLAGUE OF SMALL RUMINANTS AND INFECTIOUS BOVINE NODULAR DERMATITIS, AS WELL AS FOR MAKING DIAGNOSTIC AND PREVENTIVE VETERINARY BIOPREPARATIONS

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19910124

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19920723

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: UNISYN TECHNOLOGIES, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19951201